XML 55 R44.htm IDEA: XBRL DOCUMENT v3.23.3
Investments in Non-Marketable Securities - Narrative (Details) - USD ($)
 1 Months Ended 3 Months Ended 9 Months Ended
Mar. 31, 2023
Sep. 30, 2021
Apr. 30, 2021
Jun. 30, 2020
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Jun. 30, 2022
Mar. 31, 2022
Marketable Securities [Line Items]                      
Payments to acquire other investments             $ 1,191,000 $ 5,300,000      
Total non-marketable equity securities         $ 18,013,000   18,013,000   $ 20,510,000    
Total revenues         9,277,000 $ 34,470,000 43,582,000 108,215,000      
Impairment of investment in non-marketable equity securities         3,900,000   3,875,000 0      
Unrealized or realized gains or losses         0 0 0 0      
Research and development revenue                      
Marketable Securities [Line Items]                      
Total revenues         3,882,000 6,428,000 18,775,000 $ 14,839,000      
seqWell | Research and development revenue                      
Marketable Securities [Line Items]                      
Total revenues         $ 69,000   $ 187,000        
Common Stock | seqWell                      
Marketable Securities [Line Items]                      
Shares issued in exchange for service         65,982   179,897        
seqWell                      
Marketable Securities [Line Items]                      
Non-marketable equity securities purchased (in shares)                     1,000,000
Total non-marketable equity securities         $ 2,598,000   $ 2,598,000   5,000,000   $ 5,000,000
Impairment of investment in non-marketable equity securities         3,000,000            
Arzeda                      
Marketable Securities [Line Items]                      
Total non-marketable equity securities         444,000   $ 444,000   $ 1,289,000    
Impairment of investment in non-marketable equity securities         $ 900,000            
Series A Preferred Stock | MAI | MCRA                      
Marketable Securities [Line Items]                      
Number of shares received in exchange for services (in shares)             19,277,914        
Series C-1 Preferred Stock | seqWell                      
Marketable Securities [Line Items]                      
Non-marketable equity securities purchased (in shares)         88,256   88,256        
Series B-2 Preferred Stock | Arzeda                      
Marketable Securities [Line Items]                      
Non-marketable equity securities purchased (in shares)         207,070   207,070        
Common Stock Warrants | seqWell                      
Marketable Securities [Line Items]                      
Non-marketable equity securities purchased (in shares)         44,128   44,128        
Total non-marketable equity securities         $ 400,000   $ 400,000        
MAI                      
Marketable Securities [Line Items]                      
Unrealized gain on non-marketable securities           $ 200,000          
MAI | Series B Preferred Stock                      
Marketable Securities [Line Items]                      
Number of shares purchased (in shares) 985,545 9,198,423               1,587,049  
Payments to acquire other investments $ 800,000 $ 7,000,000                  
MAI | Series A Preferred Stock                      
Marketable Securities [Line Items]                      
Number of shares purchased (in shares)     1,000,000 1,587,050              
Payments to acquire other investments     $ 600,000 $ 1,000,000